Does myo-inositol help PCOS, insulin resistance or anxiety?

Inositol is sometimes called "vitamin B8," though it's not a true vitamin since the body can synthesize it. Its primary job is as a building block for second messengers — signaling molecules inside cells that relay instructions from hormones like insulin and FSH (follicle-stimulating hormone). When inositol is deficient or the downstream signaling is impaired, insulin receptors essentially lose their voice: insulin is present, but cells don't hear the message well³.

Insulin Sensitization

The most documented use of myo-inositol is improving insulin sensitivity. It doesn't work by blocking glucose absorption or stimulating insulin secretion — it works deeper in the chain, enhancing how cells respond once insulin binds. This makes it valuable in conditions characterized by insulin resistance: PCOS, metabolic syndrome, gestational diabetes, and type 2 diabetes risk³.

A meta-analysis of 20 randomized controlled trials involving 1,239 subjects found that inositol supplementation significantly reduced fasting blood glucose and improved insulin sensitivity — and these benefits occurred independently of weight loss². This is notable because many insulin-sensitizing interventions work largely through metabolic changes tied to weight.

Hormonal Balance in PCOS

PCOS (polycystic ovary syndrome) is the most studied condition for myo-inositol. Many women with PCOS have a defect in inositol metabolism that impairs ovarian response to FSH. Supplementing with myo-inositol appears to restore this signaling, supporting ovulation and reducing androgen excess¹.

Myo-inositol is often combined with D-chiro-inositol (DCI) in a 40:1 ratio, which mirrors the physiological ratio in the body. Research suggests this combination outperforms either compound alone for restoring hormonal balance³.

Anxiety and Panic

Inositol is also a precursor to the phosphatidylinositol signaling pathway used by serotonin receptors. Early clinical research found that high-dose inositol (12–18 g/day) reduced panic attack frequency and severity comparably to certain SSRIs — with far fewer side effects^5,6. The effect on generalized anxiety is less established, but the panic disorder research is among the more robust in nutritional psychiatry.

Practical Dosing

• PCOS / insulin resistance: 2–4 g myo-inositol per day, often with 200 mcg folic acid
• Fertility support: 2–4 g/day, usually starting 1–3 months before conception attempts
• Anxiety / panic: 12–18 g/day (used in research studies; consult a physician at this dose)
• Timing: Can be taken with or without food; splitting the dose morning and evening may improve tolerability
• Form: Powder dissolved in water is common; capsule forms also available

Inositol is generally very well tolerated. Mild GI side effects (nausea, loose stools) can occur at higher doses and usually resolve with dose reduction.

PCOS and Reproductive Outcomes

The most comprehensive recent evidence comes from a 2024 systematic review and meta-analysis by Fitz et al., which analyzed 30 trials involving 2,230 participants (19 pooled in meta-analyses) to inform the 2023 international PCOS guidelines⁸. The review found benefits of myo-inositol or D-chiro-inositol for some metabolic measures and potential benefit of D-chiro-inositol for ovulation, but inositol may have no effect on other outcomes. Myo-inositol likely causes fewer gastrointestinal side effects than metformin, while metformin may improve waist-hip ratio and hirsutism compared with inositol. The authors judged the evidence supporting inositol for PCOS limited and inconclusive.

An earlier meta-analysis by Unfer et al. (PMID 29042448, Endocrine Connections, 2017) examined 9 randomized controlled trials (247 cases, 249 controls). Myo-inositol significantly reduced fasting insulin and improved HOMA-IR; SHBG (sex hormone binding globulin, a marker of androgen excess) increased significantly after 24+ weeks. This is clinically relevant because elevated androgens in PCOS drive many of its most burdensome symptoms.

Costantino et al.⁴ conducted a double-blind trial in 42 women with PCOS comparing myo-inositol plus folic acid with folic acid alone as the placebo. Triglycerides dropped dramatically — from a mean of 195 mg/dL to 95 mg/dL — in the inositol group. Ovulation was restored in 16 of 23 women in the treatment arm, compared to just 4 of 19 in the placebo group. These are striking numbers for a non-pharmaceutical intervention.

Fertility and Egg Quality

Ciotta et al.⁷ ran a double-blind trial examining oocyte quality in PCOS patients undergoing IVF. Women received either 2 g myo-inositol + 200 mcg folic acid twice daily or 200 mcg folic acid alone twice daily for three months before egg retrieval. The inositol group showed significantly improved follicle development, higher oocyte recovery rates, and better embryo quality scores. This matters mainly for IVF patients; whether it translates to better natural conception was not tested.

Glucose and Metabolic Health

Miñambres et al. (PMID 29980312, Clinical Nutrition, 2019) conducted the most statistically rigorous meta-analysis on inositol and glucose, pooling 20 RCTs with 1,239 subjects across diverse populations (PCOS, metabolic syndrome, gestational diabetes risk). Inositol significantly reduced fasting plasma glucose and insulin resistance markers. Importantly, there was no significant effect on HbA1c or BMI, suggesting the mechanism is direct insulin sensitization rather than metabolic weight changes. This is a meaningful distinction for people who are already lean but insulin resistant.

Croze and Soulage (PMID 23764390, Biochimie, 2013) provide the most thorough mechanistic review. They describe how inositol phosphoglycans (IPGs) function as insulin second messengers — essentially relay switches that amplify the insulin signal inside cells. A deficiency in IPG availability, or genetic impairments in inositol metabolism, can cause insulin signaling to "short circuit" even when insulin levels are normal. This explains why some people with insulin resistance have normal fasting insulin but poor cellular glucose uptake.

Anxiety and Panic Disorder

The psychiatric application of inositol remains one of the more surprising areas of research. Benjamin et al. (PMID 7793450, American Journal of Psychiatry, 1995) ran a double-blind crossover trial in 21 patients with panic disorder. Participants took 12 g/day inositol or placebo for four weeks each. Inositol reduced panic attack frequency significantly more than placebo, with improvements also seen in agoraphobia ratings. Adverse effects were minimal.

Palatnik et al. (PMID 11386498, Journal of Clinical Psychopharmacology, 2001) pushed further with a head-to-head comparison against fluvoxamine (an SSRI used for panic). In a crossover design with 20 patients, inositol reduced panic attacks by 4.0 per week versus 2.4 per week for fluvoxamine. Hamilton Anxiety Scale scores improved comparably between the groups, but inositol caused significantly fewer gastrointestinal side effects. This does not mean inositol replaces SSRIs — sample sizes are small and the follow-up periods are short — but it does support inositol as a meaningful intervention for panic with a favorable tolerability profile.

Evidence Summary

The evidence for myo-inositol is strongest in PCOS (multiple meta-analyses, moderate-to-strong evidence), metabolic insulin resistance (meta-analysis of 20 RCTs), and fertility support (solid double-blind trial data). The anxiety/panic research is promising but comes from small trials conducted primarily in the 1990s and early 2000s — it warrants more large-scale replication. Inositol's excellent safety profile at standard doses (2–4 g/day) makes it a reasonable option to discuss with a healthcare provider for the conditions above.